Switching AI Scribes Without Losing a Clinic Day

Switching AI scribes is mostly two jobs, not a project: get your old notes out before you lose access, and prove the new tool on real visits before you cancel anything. Do those in the right order and you never lose a clinic day, because your current scribe keeps working while you test the next one in parallel. This page is the cutover checklist, 12 steps, plus a parallel-trial protocol that grades both tools on the same real clinic day. No faith required, just a week of evidence.

In the self-serve band there's no integration to unwind, so the danger isn't difficulty. It's switching blind: canceling on a demo's promise, losing notes you didn't export, or signing up for a launch price that resets in year two. The checklist below removes each of those.

Key takeaways

• Switching self-serve scribes is low-risk if you do it in order: export old notes first, trial the new tool in parallel, cancel last.
• The parallel trial runs both scribes on the same real clinic day, so there's never a gap and you grade notes on your own visits, not a demo.
• Export before you cancel: access usually ends with billing, and if you enabled an optional note auto-delete window, older notes may already be gone.
• Confirm year-two pricing in writing, a BAA (US) or DPDP consent handling (India), and a one-sentence audio answer before you commit.

Why do clinicians switch AI scribes?

Rarely on a whim. Three patterns drive it. The price changed, a launch or promo rate reset higher at renewal, or a feature you use moved up a tier. The tool missed your reality, it stumbled on your accents, your languages, your noisy OPD, or the multi-speaker room you actually work in. Or the gaps showed, no prescription draft, no ICD-10 suggestions, audio retained longer than you're comfortable with, a support queue that went quiet.

Whatever the trigger, the switch itself is the same shape. You're trading a known tool for a better-fitting one, and the only real risk is doing it carelessly. If any of those triggers sound like your week, you can book a demo and see the alternative before you plan the move.

The 12-step cutover checklist

Do these in order. The order is the point: export before you cancel, test before you commit, cancel last.

1. Write down why you're switching. One sentence. It becomes your grading criterion later, so be specific: "ICD-10 is behind a tier I won't pay for," not "it's annoying."
2. List the clinical output you need. Note only, or note plus ICD-10 suggestions plus a prescription draft? Write the must-haves so you compare like for like, not feature-sheet against feature-sheet.
3. Check your current tool's note auto-delete setting. Some scribes offer an optional auto-delete window for notes. If it's on, older notes may already be gone, so check before you assume they're waiting for you.
4. Export every note you want to keep. Pull them into your EHR or local storage now, while you still have access. Access usually ends the day billing does.
5. Confirm what your current tool does with audio, and when it deletes it. You want this on record before you leave, especially if a patient or court ever asks.
6. Shortlist the replacement on the things that matter: published year-two pricing, a BAA (US) or DPDP consent handling (India), the clinical output from step 2, and a one-sentence audio answer.
7. Start the new tool's free trial, but don't cancel anything yet. The old scribe stays live.
8. Run the parallel trial (the protocol is in the next section). Both tools, same real visits, one clinic day minimum, a week is better.
9. Grade the notes side by side against your sentence from step 1 and your list from step 2. Use your own visits, not the demo's.
10. Get year-two pricing in writing. Launch and promo rates reset; a published ladder you can read beats a number you have to ask for.
11. Only now, cancel the old subscription, after the new tool has proven itself on real visits and your old notes are safely exported.
12. Keep your export for the record. Even after you switch, your old notes are part of the chart history. Store them where your retention policy lives.

You'll notice nothing in that list is technical. That's the self-serve advantage: no integration project, no data-migration vendor, no downtime. The work is discipline, not engineering.

The parallel-trial protocol: run both on one real clinic day

Demos flatter every scribe equally. The only test that tells you anything is your own clinic day, run through both tools at once. Here's the protocol.

Pick one normal clinic day. Not your easiest, not your hardest, a representative Tuesday with your usual mix of visit types, accents, and languages.

Run your current scribe as your live tool. Nothing changes in your workflow; it's still your real documentation. This is what guarantees you don't lose the day.

Run the new scribe in parallel on the same visits, using its free trial. Most self-serve tools, including ours, offer a 7-day no-card trial, so the parallel run costs you nothing. You're capturing the same conversations twice.

When the day ends, put the two notes side by side for each visit and grade them on what actually matters to you:

The tool that wins your grading wins, full stop. A scripted demo can't show you this because it doesn't have your patients in it.

Run this for a single day and you'll know more than any feature comparison can tell you. Run it for a week and you've removed the risk from the switch entirely. That's the whole pitch for trying ours: run the 7-day trial on a real clinic week, in parallel with whatever you use now.

What to check before you commit to the new tool

The trial proves note quality. These four checks prove you won't regret the switch in six months.

Year-two pricing, in writing. Launch rates and promo rates reset. Ask for the full ladder, what you pay now, what you pay at renewal, what each tier includes. We publish ours with no asterisks on the pricing page, which is the standard to hold every vendor to.

A BAA (US) or clear DPDP handling (India). In the US, a signed BAA is the floor; don't switch to a tool that won't sign one for your practice size. In India, the DPDP Act 2023 frame is consent-first and purpose-limited, so the question is how the vendor handles consent and what it does with data.

A one-sentence audio answer. "Where does the audio live, and for how long?" A vendor who can't answer that in one sentence has answered it. Ours: AI Scribe by Patient Square is an ambient AI medical scribe that listens during the visit and hands back a structured SOAP note, ICD-10 suggestions, and a prescription draft, ready to review and sign about two minutes after the visit, and visit audio is processed in memory and discarded the moment the note drafts, so there's no recording retained. The full posture is on the security page.

The clinical output you actually use. If you need ICD-10 suggestions and a prescription draft, confirm they're included, not gated a tier up. No feature gating between our tiers means you don't discover the gap after you've switched.

Which alternative should you switch to?

That depends on what you're leaving and why. We've written the honest fit pages for the tools clinicians most often compare:

• Coming from the established self-serve incumbent? Freed alternatives covers what Core includes, what sits a tier up, and the switch checklist for that specific move.
• Weighing an enterprise platform you've outgrown the need for? Abridge alternatives is the enterprise-versus-independent fit call, and Dragon Copilot alternatives covers the EHR-embedded, Epic-native end.
• Leaving a voice-command tool? Suki alternatives lays out voice-command versus ambient-first.
• Want the whole field at once? Our best AI medical scribes comparison is the honest roundup, with when-each-fits-better verdicts.

Each of those pages says, by name, when the tool you're leaving is actually the better fit, because pretending otherwise would make the rest untrustworthy.

When you should not switch (said plainly)

We'll give the verdict without hedging, because the honest version is the useful one.

Don't switch if your current tool already does the job at a fair price. If you're on a scribe that drafts clean notes, signs a BAA, handles your languages, and isn't about to reprice you, switching for a marginal feature is churn you don't need. The grass-is-greener move costs you a week of parallel trialing for little gain.

Switch when the parallel trial proves a real difference on your visits. If the new tool grades clearly better on your own accents, languages, and visit types, or includes output your current one gates, or publishes a price your current one hides, the switch pays for itself fast. The trial is how you tell the two situations apart.

The rule is simple: never switch on a demo, always switch on a graded clinic day.

How to switch in a week

1. Day 1: export your old notes, check the auto-delete setting, write your one-sentence reason.
2. Day 2: start the new tool's trial; keep the old one live.
3. Days 2 to 6: run the parallel trial on real visits; grade notes side by side daily.
4. Day 6: get year-two pricing in writing; confirm BAA or DPDP handling and the audio answer.
5. Day 7: if the new tool won your grading, cancel the old one, keep your export.

The price ladder with no asterisks is on the pricing page, and the security receipts are on the security page. Book a short demo to see the alternative against your own visit type, then run the 7-day trial in parallel with whatever you use now. Done in this order, you switch without losing a note, a clinic day, or your old data.